查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2004022

固化劑市場：按類型、應用、終端用戶產業和形態分類－2026-2032年全球市場預測

Curing Agent Market by Curing Agent Type, Application, End Use Industry, Form - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年硬化劑市值為88.7億美元，預計到2026年將成長至92.4億美元，複合年成長率為5.82%，到2032年將達到131.9億美元。

主要市場統計數據
基準年 2025 88.7億美元
預計年份：2026年 92.4億美元
預測年份 2032 131.9億美元
複合年成長率 (%) 5.82%

這本權威的入門書籍概述了固化劑的化學演變、應用要求、供應鏈影響以及影響產業決策的策略重點。

固化劑市場的發展趨勢體現了化學技術創新、應用主導的性能要求以及不斷變化的監管和貿易環境的融合。近年來，製造商和化合物設計人員越來越重視縮短固化時間、提高熱性能和機械性能以及更好地符合環境法規。這種環境推動了關鍵固化化學領域的產品差異化，並進一步提高了對特定應用配方的關注，例如需要更高耐化學性的塗料、需要更高黏接強度的黏合劑，以及必須平衡加工窗口和最終用途特性的複合材料基體。

對技術、法規和供應鏈促進因素進行前瞻性審查，全面重組固化劑的開發、採購和商業化策略。

固化劑產業正經歷一場變革，這場變革正在重塑傳統的價值鏈，其驅動力來自於技術、監管和終端應用領域的轉變。首先，由於電氣化和輕量化的發展，性能最佳化日益受到重視。能夠實現高熱穩定性、增強對新型基材的黏合性以及縮短固化週期的配方正成為優先考慮的對象。因此，開發平臺目前主要集中在多功能化學技術和混合固化方法，這些技術和方法既能滿足嚴格的機械和熱性能要求，又能應對現代生產效率的限制。

詳細檢驗關稅到 2025 年的累積影響，以及貿易措施如何促進供應鏈中的回流、供應商替代和適應性創新。

關稅措施和貿易政策調整已成為影響整個硬化劑生態系統原料流動、採購效率和競爭地位的關鍵工具。 2025年實施的政策變化已導致成本結構重組，並引發供應商和消費者的策略性回應。對許多製造商而言，日益收緊的關稅環境凸顯了供應基地地域多元化的重要性，並提升了近岸外包作為降低跨洋供應中斷風險手段的作用。企業日益認知到，在更靠近終端市場的地方採購或生產可以減少前置作業時間波動，並起到緩衝關稅突然上漲的作用，同時，企業也越來越重視區域生產能力，將其視為一種風險管理資產。

基於細分的詳細分析，將固化劑的化學性質、應用要求、最終用途產業要求和物理形態選擇連結起來，以幫助制定配方和採購決策。

要了解市場，需要從細分觀點固化劑的化學性質與其應用、終端用戶產業和物理形態聯繫起來，因為每個維度都存在獨特的技術和商業性限制。根據固化劑的類型，該行業涵蓋了酸酐、異氰酸酯、酚類和多胺類等化學性質。酸酐分為甲基六氫鄰苯二甲酸酐、納迪克甲基酸酐和鄰苯二甲酸酐，每種酸酐具有獨特的反應活性和熱性能，使其適用於特定的樹脂系統和固化條件。異氰酸酯又分為MDI和TDI，它們在官能基和應用適用性方面有所不同，在聚氨酯系統中發揮著核心作用，因為聚氨酯系統的剛度、柔軟性和固化速度需要進行精細的平衡。酚類化合物，包括酚醛樹脂和可溶酚醛樹脂樹脂，具有優異的耐熱性和耐溶劑性，適用於高溫塗料和複合材料基體應用；而聚胺，包括脂族胺、芳香族胺和環狀脂族胺胺，具有廣泛的固化速率和適用期，可用於黏合劑、塗料和澆鑄配方。

區域比較分析顯示美洲、歐洲、中東和非洲以及亞太地區的趨勢如何影響固化劑產業的供應鏈、法規和技術採用。

區域趨勢對固化劑市場的整體競爭地位、供應鏈韌性和創新軌跡有顯著影響。在美洲，製造商和目的地受益於成熟的化學品生產基礎設施以及接近性大規模汽車、航太和電子市場的地理優勢。該地區支援快速的產品上市週期，並促進原料供應商和原始設備製造商 (OEM) 之間的合作關係。然而，該地區的優先事項還包括將生產轉移到國內以及製定庫存策略，以降低海上運輸中斷和貿易波動帶來的風險，這些因素會影響供應商的選擇和投資規劃。

深入了解技術領先地位、專業創新和整合技術服務如何決定供應商選擇中的競爭地位和長期客戶關係。

固化劑產業的競爭動態呈現出多元化的特點，既有跨國化工製造商，也有專業配方商和利基創新企業，它們各自憑藉技術實力、規模優勢和緊密的客戶關係展開競爭。領先的供應商透過豐富的產品系列、強大的應用工程能力以及支援準時交貨和技術服務的全球物流網路來脫穎而出。這些能力對於那些需要在規模化生產過程中快速解決問題、需要針對特定基材定製配方或需要受監管行業檢驗的性能數據的客戶至關重要。

為領導者提供切實可行的策略建議，以協調研發、採購、永續發展和商業職能，從而實現以績效為導向且具韌性的價值。

產業領導企業可以透過在創新、供應鏈、商業和監管等領域採取有針對性的舉措，將不斷變化的產業格局轉化為競爭優勢。首先，他們應優先制定產品組合策略，將固化化學與電動動力傳動系統、航太複合材料和先進電子產品等高成長應用領域結合。這需要集中投入研發，以最佳化反應特性並檢驗其在特定應用應力條件下的性能，從而加速原始設備製造商 (OEM) 和一級供應商的採用。

一種透明且可重複的研究途徑，結合了初步訪談、技術文獻整合、產業分析和情境建模，以支持策略洞察。

本分析的調查方法融合了定性和定量方法，旨在對固化劑的現狀形成可靠且基於實證的理解。關鍵資料來源包括對配方、研發、採購和終端用戶等領域的技術負責人進行結構化訪談，從而獲得關於性能要求、採購政策和新興應用需求的第一手資訊。此外，本研究還輔以技術文獻綜述、專利分析和監管文件，以檢驗技術趨勢和合規性考量。

簡明扼要地總結了績效要求、供應彈性和監管措施如何相互交織，從而界定競爭優勢和策略重點。

總之，固化劑市場格局的特點是技術要求不斷提高、監管日益複雜以及供應鏈重組。積極調整其化學產品系列相關人員主導應用性能要求、投資於永續數位化開發流程並增強供應鏈韌性的利益相關者，將能夠獲得差異化價值。在這個性能、可靠性和合規應對力至關重要的市場中，配方創新、區域生產策略和高度靈活的商業模式的相互作用將決定最終的贏家。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：硬化劑市場－依硬化劑類型分類

  • 酸酐
    • 甲基六氫鄰苯二甲酸酐
    • 納迪克甲基酐
    • 鄰苯二甲酸酐
  • 異氰酸酯
    • MDI
    • TDI
  • 酚類
    • 諾沃拉克
    • 可溶酚醛樹脂
  • 多胺
    • 脂族胺
    • 芳香胺
    • 脂族胺

第9章：固化劑市場：依應用領域分類

  • 黏合劑
  • 鑄件
  • 塗層
  • 複合材料
  • 電子設備

第10章：固化劑市場：依最終用途產業分類

  • 航太
  • 車
  • 建造
  • 電氣和電子
  • 船

第11章：固化劑市場：以劑型分類

  • 液體
  • 粉末
  • 固體的

第12章：硬化劑市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：固化劑市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：硬化劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國硬化劑市場

第16章：中國硬化劑市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Aditya Birla Group
  • Air Products and Chemicals Inc
  • Akzo Nobel NV
  • Albemarle Corporation
  • Allnex Belgium SA
  • Arkema SA
  • Ashland Global Holdings Inc
  • Atul Ltd
  • BASF SE
  • Cardolite Corporation
  • Covestro AG
  • DIC Corporation
  • Dow Inc
  • Evonik Industries AG
  • Gabriel Performance Products
  • Hexion Inc
  • Huntsman Corporation
  • Incorez Ltd
  • Kukdo Chemical Co Ltd
  • LANXESS AG
  • Mitsubishi Chemical Corporation
  • Momentive Performance Materials Inc
  • Olin Corporation
  • Reichhold LLC
  • Wanhua Chemical Group Co Ltd
Product Code: MRR-4659C8712BC6

The Curing Agent Market was valued at USD 8.87 billion in 2025 and is projected to grow to USD 9.24 billion in 2026, with a CAGR of 5.82%, reaching USD 13.19 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.87 billion
Estimated Year [2026] USD 9.24 billion
Forecast Year [2032] USD 13.19 billion
CAGR (%) 5.82%

An authoritative introduction that frames curing agent chemical evolution, application imperatives, supply chain influences, and strategic priorities shaping industry decisions

The curing agent landscape is defined by a convergence of chemical innovation, application-driven performance demands, and evolving regulatory and trade environments. Over recent years, manufacturers and formulators have increasingly oriented their strategies around the need for faster cure schedules, enhanced thermal and mechanical performance, and greater environmental compliance. This environment has stimulated incremental product differentiation across core curing chemistries and has intensified the focus on application-specific formulations, whether for coatings that require tougher chemical resistance, adhesives that demand improved bond durability, or composite matrices that must balance processing window and end-use properties.

At the same time, advancements in polymer science and catalyst technologies have expanded the design space available to chemists, enabling finer control over cure kinetics and network architecture. These technical developments are complemented by shifts in end-use sectors that place premium value on weight savings, electrical performance, and longevity-factors that are especially pronounced in aerospace, automotive electrification, and advanced electronics. Consequently, stakeholders from raw material suppliers to OEMs are increasingly assessing curing agents not only for immediate functionality but also for lifecycle performance, recyclability, and compatibility with next-generation substrates.

In parallel, supply chain dynamics and trade policy have influenced procurement strategies and risk tolerance, prompting firms to reassess sourcing geographies and vendor portfolios. This introduction establishes the foundational context for a deeper examination of transformative market shifts, tariff impacts, segmentation-driven insights, regional comparisons, competitive positioning, and recommended actions tailored to industry leaders. The subsequent sections will synthesize these themes into actionable intelligence that supports decision-making across R&D, procurement, and corporate strategy functions.

A forward-looking synthesis of technological, regulatory, and supply chain accelerants that are collectively reshaping curing agent development, sourcing, and commercialization strategies

The curing agent sector is undergoing transformative shifts driven by technological, regulatory, and end-use transitions that together are rewriting traditional value chains. First, there is an intensified emphasis on performance optimization tied to electrification and lightweighting initiatives; formulations that deliver high thermal stability, enhanced adhesion to novel substrates, and shortened cure cycles are being prioritized. As a result, research and development pipelines now frequently target multifunctional chemistries and hybrid curing approaches that can meet stringent mechanical and thermal specifications while remaining compatible with modern manufacturing throughput constraints.

Secondly, sustainability and circularity considerations have moved from peripheral concerns to central design criteria. Manufacturers are adopting low-VOC and bio-derived precursor strategies, and there is heightened attention to end-of-life pathways and recyclability. Consequently, curing agents that facilitate lower energy curing profiles or that are derived from less hazardous feedstocks are attracting increased interest from both customers and regulators. This orientation is prompting suppliers to invest in greener synthesis routes and to validate environmental credentials through rigorous testing and documentation.

Thirdly, digitalization and advanced process control are changing how formulations are developed and deployed. Predictive modeling of cure kinetics, enabled by improved data capture and analytics, reduces development cycles and improves scale-up reliability. Adopters are leveraging these capabilities to shorten time-to-market for new formulations and to optimize production yields, thereby lowering total cost of ownership. Finally, geopolitical events and trade policy adjustments have accelerated supplier diversification and strategic inventory management, encouraging vertical integration in some parts of the supply chain. Taken together, these shifts are producing a more resilient, innovation-driven landscape where chemistry, sustainability, and digital capability determine competitive advantage.

A nuanced examination of cumulative tariff impacts through 2025 and how trade measures have compelled reshoring, sourcing substitutions, and adaptive innovation across the supply chain

Tariff actions and trade policy adjustments have become influential levers that affect raw material flows, procurement economics, and competitive positioning across the curing agent ecosystem. The policy changes implemented through 2025 have introduced reframed cost structures and prompted strategic responses from both suppliers and consumers. For many manufacturers, the heightened tariff environment has reinforced the importance of geographic diversification across supply bases and has elevated the role of nearshoring as a tool to mitigate exposure to transoceanic supply interruptions. Firms have increasingly evaluated regional production capability as a risk-management asset, recognizing that the ability to source or manufacture proximate to end-use markets can reduce lead-time volatility and provide buffering against sudden tariff escalations.

In parallel, tariff-driven cost pressures have encouraged reconfigurations of sourcing strategies that emphasize raw material substitution where technically feasible, longer-term supplier contracts to lock in pricing stability, and collaborative cost-sharing arrangements for qualifying high-volume buyers. These mechanisms have been complemented by industry efforts to optimize formulations to reduce dependence on the most tariff-sensitive feedstocks. At the same time, the tariff landscape has incentivized some suppliers to localize intermediate manufacturing to maintain price parity and customer loyalty in affected markets. Such localization often involves balancing capital expenditure against the anticipated duration and severity of trade measures, leading to a nuanced calculus around investment timing and scale.

Critically, trade policy changes have also had downstream effects on innovation timelines. When tariffs increase component costs, R&D priorities may shift toward developing more material-efficient systems or alternative curing chemistries that deliver equivalent performance with different raw material inputs. Conversely, stable trade conditions have the potential to accelerate collaborative innovation across borders by reducing the transactional friction associated with cross-border material flows. In summary, the cumulative tariff environment through 2025 has prompted adaptive strategies across procurement, manufacturing footprint, and product development that collectively alter competitive dynamics and the pace of technological adoption.

A detailed segmentation-driven analysis linking curing chemistries, application demands, end-use industry requirements, and physical form choices to inform formulation and sourcing decisions

Understanding the market requires a segmentation lens that links curing chemistries to applications, end-use industries, and physical form factors because each dimension exerts distinct technical and commercial constraints. Based on curing agent type, the industry spans anhydride, isocyanate, phenolic, and polyamine chemistries. Anhydrides are differentiated into methylhexahydrophthalic anhydride, nadic methyl anhydride, and phthalic anhydride, each offering unique reactivity profiles and thermal performance that make them suitable for specific resin systems and cure regimes. Isocyanates subdivide into MDI and TDI, which differ in functionality and application suitability and play central roles in polyurethane systems where stiffness, flexibility, and cure speed are finely balanced. Phenolic systems, including novolac and resole types, bring thermal resistance and solvent tolerance favored in high-temperature coatings and composite matrices, while polyamines-encompassing aliphatic amine, aromatic amine, and cycloaliphatic amine classes-provide a spectrum of cure kinetics and pot-life characteristics that are exploited across adhesives, coatings, and casting formulations.

When viewed through the application axis, key uses include adhesives, castings, coatings, composites, and electronics, each imposing distinct performance specifications that guide chemistry selection and formulation strategy. For instance, adhesives demand balanced adhesion to diverse substrates and often require curing agents that enable high bond strength with controlled shrinkage, whereas casting systems prioritize dimensional stability and thermal resistance. Coatings emphasize surface properties, weatherability, and processability, while composites require curing agents compatible with fiber reinforcements and capable of delivering the mechanical performance and thermal stability needed for weight-sensitive sectors. Electronics applications increasingly demand low ionic content, thermal management capabilities, and minimal outgassing, prompting selection of curing agents that meet stringent reliability criteria.

From the perspective of end-use industry segmentation-encompassing aerospace, automotive, construction, electrical and electronics, and marine-the performance envelope varies considerably. Aerospace formulators prioritize extreme thermal and fatigue performance, often leveraging high-performance phenolic or specialized anhydride systems. Automotive demand is driven by both structural adhesives for lightweighting and coating systems for durability and appearance, with electrification trends elevating needs for thermal conductivity and dielectric stability. Construction applications emphasize cost-effectiveness and long-term durability, while marine sectors require chemical resistance and UV stability. Electronics industries increasingly focus on miniaturization and thermal management, steering demand toward curing agents that provide reliable thermal interfaces and consistent dielectric behavior.

Finally, form factors-liquid, powder, and solid-shape logistics, processing, and end-use applicability. Liquids offer ease of mixing and are predominant in coatings and adhesives, powders provide dust-free handling and are favored for certain powder coating and composite prepreg applications, and solids may be used for preforms or specialized casting systems. The interplay among chemistry type, application, end-use requirements, and form factor creates a multidimensional decision matrix for formulators and procurement specialists, where trade-offs between performance, process efficiency, and cost must be navigated. This segmentation-driven view enables stakeholders to align product development and sourcing strategies with precise technical requirements and commercial constraints.

A regional comparative analysis showing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics shape supply chains, regulation, and technology adoption in curing agents

Regional dynamics profoundly influence competitive positioning, supply chain resilience, and innovation trajectories across the curing agent landscape. In the Americas, manufacturers and end users benefit from established chemical production infrastructure and proximity to large automotive, aerospace, and electronics markets. This geography supports rapid commercialization cycles and facilitates collaborative partnerships between raw material suppliers and OEMs. However, regional priorities also include onshoring initiatives and inventory strategies that mitigate exposure to ocean freight disruptions and trade volatility, which in turn shapes supplier selection and investment planning.

In Europe, the Middle East & Africa cluster, regulatory rigor and sustainability mandates are prominent drivers of product development. Stricter emissions and waste-management frameworks incentivize adoption of lower-VOC formulations and green chemistry pathways. Additionally, the presence of advanced aerospace and automotive supply chains in parts of Europe creates demand for high-performance curing agents with validated lifecycle credentials. The Middle East component of the region emphasizes feedstock availability and petrochemical integration, while select African markets are gradually increasing adoption in construction and infrastructure projects, albeit at variable pace.

Asia-Pacific represents a diverse and rapidly evolving landscape characterized by strong manufacturing capacity, expanding electronics and automotive hubs, and significant investments in advanced materials research. The region is a major consumer of curing chemistries for both large-volume industrial applications and specialized high-performance uses. Local supplier bases are expanding their technical portfolios to meet domestic demand and export opportunities, and policymakers' focus on industrial competitiveness and technology upgrading continues to influence capital allocation and R&D collaborations. Across these regions, differences in regulatory regimes, feedstock access, and end-market composition create distinct strategic imperatives for suppliers and buyers, necessitating region-specific approaches to production footprint, commercial engagement, and regulatory compliance.

An insightful look at competitive positioning where technology leadership, specialty innovation, and integrated technical services determine supplier preference and long-term customer ties

Competitive dynamics in the curing agent domain are shaped by a mix of multinational chemical producers, specialty formulators, and niche innovators who compete on the basis of technology, scale, and customer intimacy. Leading suppliers differentiate through deep product portfolios, application engineering capabilities, and global logistics networks that support just-in-time delivery and technical service. These capabilities prove critical for customers who require rapid troubleshooting during scale-up, tailored formulations for unique substrates, or validated performance data for regulated industries.

Simultaneously, specialist firms and startups are carving out positions by focusing on single-chemistry platforms, green synthesis routes, or advanced catalysts that accelerate cure or extend pot life. Their agility enables faster iteration cycles and closer partnerships with OEMs exploring novel composites or electronics packaging. Strategic collaborations between large incumbents and technology-focused smaller players are increasingly common, enabling incumbents to access innovation while offering scale and global market access to emerging technologies.

Across the competitive landscape, value is also being captured through services adjacent to the core chemistry offering. These include formulation advisory services, application-specific testing programs, and digital tools to model cure kinetics and performance under varying processing conditions. Providers that combine product excellence with consultative support create higher switching costs and deeper customer relationships. As procurement expectations evolve, suppliers that can demonstrate performance reliability, regulatory compliance, and supply continuity will secure preferential positions in long-term contracts and development partnerships.

Actionable strategic recommendations for leaders to align R&D, sourcing, sustainability, and commercial capabilities to capture performance-driven and resilience-focused value

Industry leaders can translate the evolving landscape into competitive advantage by pursuing targeted actions across innovation, supply chain, commercial, and regulatory domains. First, prioritize portfolio strategies that align curing chemistries with high-growth application areas such as electrified powertrains, aerospace composites, and advanced electronics. This requires focused R&D investments to tailor reactivity profiles and to validate performance under application-specific stressors, thereby accelerating acceptance by OEMs and tiered suppliers.

Second, strengthen supply chain resilience by diversifying feedstock sources and considering regional production or toll-manufacturing agreements that reduce exposure to trade disruptions. Complement these structural moves with contractual mechanisms-such as multi-year supply agreements and collaborative inventory management-to stabilize costs and guarantee availability for critical programs. In parallel, evaluate opportunities for backward integration or strategic partnerships that secure access to key intermediates.

Third, embed sustainability and regulatory readiness into product roadmaps. Invest in greener synthesis routes, substantiated life-cycle analyses, and transparent regulatory documentation to meet tightening environmental and customer standards. These investments will reduce regulatory risk and can unlock preference among customers seeking to decarbonize their supply chains. Fourth, adopt digital tools and modeling platforms to accelerate formulation development and scale-up. Predictive analytics and process simulation can shorten lead times and reduce trial-and-error in manufacturing transitions.

Finally, enhance go-to-market capabilities by coupling technical service with commercial flexibility. Offer value-added services such as application testing, co-development frameworks, and modular licensing models. This dual focus on technical excellence and customer enablement will deepen relationships, create barriers to substitution, and provide a platform for capturing premium pricing where validated performance advantages exist.

A transparent and reproducible research approach combining primary interviews, technical literature synthesis, trade analysis, and scenario modeling to underpin strategic findings

The research methodology underpinning this analysis integrates qualitative and quantitative approaches to produce a robust, evidence-based understanding of the curing agent landscape. Primary inputs include structured interviews with technical leaders across formulation, R&D, procurement, and end-user functions, which provide firsthand insights into performance requirements, sourcing preferences, and emerging application needs. These interviews are complemented by secondary technical literature reviews, patent analysis, and regulatory documentation to validate technological trends and compliance considerations.

Supply chain and trade dynamics were assessed through analysis of production footprints, shipping patterns, and publicly available trade policy announcements to identify how tariff shifts influence sourcing behavior and investment decisions. Competitive positioning insights were derived from company disclosures, product releases, and observed collaboration patterns, with particular attention to partnerships that accelerate commercialization of specialized chemistries. Scenario analysis was employed to examine the potential implications of varying trade and regulatory environments on procurement strategies and innovation timelines.

Throughout the research process, triangulation was used to reconcile divergent data points and to ensure the conclusions reflect a balanced synthesis of market perspectives. Care was taken to avoid overreliance on any single data source, and cross-validation techniques were applied to corroborate technical claims and reported strategic initiatives. The methodology emphasizes transparency, repeatability, and alignment with industry best practices for materials and chemical market intelligence.

A concise conclusion synthesizing how performance demands, supply resilience, and regulatory action converge to define competitive advantage and strategic priorities

In closing, the curing agent landscape is marked by accelerating technical demands, regulatory complexity, and supply chain reconfiguration. Stakeholders that proactively align chemistry portfolios with application-driven performance needs, invest in sustainable and digitally enabled development processes, and shore up supply chain resilience will be positioned to capture differentiated value. The interplay among formulation innovation, regional production strategy, and adaptive commercial models will determine winners in a market where performance, reliability, and regulatory readiness are paramount.

Looking ahead, the most consequential differentiators will be the ability to anticipate end-use transitions-such as electrification and lightweighting-and to rapidly translate those anticipated demands into validated, manufacturable formulations. Organizations that pair deep technical capability with agile sourcing and collaborative customer engagement will reduce time-to-adoption and increase the likelihood of securing long-term partnerships. Ultimately, the synthesis presented here is intended to equip decision-makers with the context and recommendations needed to prioritize investments, design resilient supply strategies, and pursue innovation pathways that align with evolving industry imperatives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Curing Agent Market, by Curing Agent Type

  • 8.1. Anhydride
    • 8.1.1. Methylhexahydrophthalic Anhydride
    • 8.1.2. Nadic Methyl Anhydride
    • 8.1.3. Phthalic Anhydride
  • 8.2. Isocyanate
    • 8.2.1. MDI
    • 8.2.2. TDI
  • 8.3. Phenolic
    • 8.3.1. Novolac
    • 8.3.2. Resole
  • 8.4. Polyamine
    • 8.4.1. Aliphatic Amine
    • 8.4.2. Aromatic Amine
    • 8.4.3. Cycloaliphatic Amine

9. Curing Agent Market, by Application

  • 9.1. Adhesives
  • 9.2. Castings
  • 9.3. Coatings
  • 9.4. Composites
  • 9.5. Electronics

10. Curing Agent Market, by End Use Industry

  • 10.1. Aerospace
  • 10.2. Automotive
  • 10.3. Construction
  • 10.4. Electrical And Electronics
  • 10.5. Marine

11. Curing Agent Market, by Form

  • 11.1. Liquid
  • 11.2. Powder
  • 11.3. Solid

12. Curing Agent Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Curing Agent Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Curing Agent Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Curing Agent Market

16. China Curing Agent Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aditya Birla Group
  • 17.6. Air Products and Chemicals Inc
  • 17.7. Akzo Nobel N.V.
  • 17.8. Albemarle Corporation
  • 17.9. Allnex Belgium SA
  • 17.10. Arkema SA
  • 17.11. Ashland Global Holdings Inc
  • 17.12. Atul Ltd
  • 17.13. BASF SE
  • 17.14. Cardolite Corporation
  • 17.15. Covestro AG
  • 17.16. DIC Corporation
  • 17.17. Dow Inc
  • 17.18. Evonik Industries AG
  • 17.19. Gabriel Performance Products
  • 17.20. Hexion Inc
  • 17.21. Huntsman Corporation
  • 17.22. Incorez Ltd
  • 17.23. Kukdo Chemical Co Ltd
  • 17.24. LANXESS AG
  • 17.25. Mitsubishi Chemical Corporation
  • 17.26. Momentive Performance Materials Inc
  • 17.27. Olin Corporation
  • 17.28. Reichhold LLC
  • 17.29. Wanhua Chemical Group Co Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL CURING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CURING AGENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CURING AGENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CURING AGENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CURING AGENT MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CURING AGENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CURING AGENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CURING AGENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CURING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CURING AGENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CURING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CURING AGENT MARKET SIZE, BY ANHYDRIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CURING AGENT MARKET SIZE, BY ANHYDRIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CURING AGENT MARKET SIZE, BY ANHYDRIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CURING AGENT MARKET SIZE, BY METHYLHEXAHYDROPHTHALIC ANHYDRIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CURING AGENT MARKET SIZE, BY METHYLHEXAHYDROPHTHALIC ANHYDRIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CURING AGENT MARKET SIZE, BY METHYLHEXAHYDROPHTHALIC ANHYDRIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CURING AGENT MARKET SIZE, BY NADIC METHYL ANHYDRIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CURING AGENT MARKET SIZE, BY NADIC METHYL ANHYDRIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CURING AGENT MARKET SIZE, BY NADIC METHYL ANHYDRIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CURING AGENT MARKET SIZE, BY PHTHALIC ANHYDRIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CURING AGENT MARKET SIZE, BY PHTHALIC ANHYDRIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CURING AGENT MARKET SIZE, BY PHTHALIC ANHYDRIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CURING AGENT MARKET SIZE, BY ISOCYANATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CURING AGENT MARKET SIZE, BY ISOCYANATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CURING AGENT MARKET SIZE, BY ISOCYANATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CURING AGENT MARKET SIZE, BY MDI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CURING AGENT MARKET SIZE, BY MDI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CURING AGENT MARKET SIZE, BY MDI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CURING AGENT MARKET SIZE, BY TDI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CURING AGENT MARKET SIZE, BY TDI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CURING AGENT MARKET SIZE, BY TDI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CURING AGENT MARKET SIZE, BY PHENOLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CURING AGENT MARKET SIZE, BY PHENOLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CURING AGENT MARKET SIZE, BY PHENOLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CURING AGENT MARKET SIZE, BY NOVOLAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CURING AGENT MARKET SIZE, BY NOVOLAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CURING AGENT MARKET SIZE, BY NOVOLAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CURING AGENT MARKET SIZE, BY RESOLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CURING AGENT MARKET SIZE, BY RESOLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CURING AGENT MARKET SIZE, BY RESOLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CURING AGENT MARKET SIZE, BY POLYAMINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CURING AGENT MARKET SIZE, BY POLYAMINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CURING AGENT MARKET SIZE, BY POLYAMINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CURING AGENT MARKET SIZE, BY ALIPHATIC AMINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CURING AGENT MARKET SIZE, BY ALIPHATIC AMINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CURING AGENT MARKET SIZE, BY ALIPHATIC AMINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CURING AGENT MARKET SIZE, BY AROMATIC AMINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CURING AGENT MARKET SIZE, BY AROMATIC AMINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CURING AGENT MARKET SIZE, BY AROMATIC AMINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CURING AGENT MARKET SIZE, BY CYCLOALIPHATIC AMINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CURING AGENT MARKET SIZE, BY CYCLOALIPHATIC AMINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CURING AGENT MARKET SIZE, BY CYCLOALIPHATIC AMINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CURING AGENT MARKET SIZE, BY ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CURING AGENT MARKET SIZE, BY ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CURING AGENT MARKET SIZE, BY ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CURING AGENT MARKET SIZE, BY CASTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CURING AGENT MARKET SIZE, BY CASTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CURING AGENT MARKET SIZE, BY CASTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CURING AGENT MARKET SIZE, BY COATINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CURING AGENT MARKET SIZE, BY COATINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CURING AGENT MARKET SIZE, BY COATINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CURING AGENT MARKET SIZE, BY COMPOSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CURING AGENT MARKET SIZE, BY COMPOSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CURING AGENT MARKET SIZE, BY COMPOSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CURING AGENT MARKET SIZE, BY ELECTRONICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CURING AGENT MARKET SIZE, BY ELECTRONICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CURING AGENT MARKET SIZE, BY ELECTRONICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CURING AGENT MARKET SIZE, BY AEROSPACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CURING AGENT MARKET SIZE, BY AEROSPACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CURING AGENT MARKET SIZE, BY AEROSPACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CURING AGENT MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CURING AGENT MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CURING AGENT MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CURING AGENT MARKET SIZE, BY CONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CURING AGENT MARKET SIZE, BY CONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CURING AGENT MARKET SIZE, BY CONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CURING AGENT MARKET SIZE, BY ELECTRICAL AND ELECTRONICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CURING AGENT MARKET SIZE, BY ELECTRICAL AND ELECTRONICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CURING AGENT MARKET SIZE, BY ELECTRICAL AND ELECTRONICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CURING AGENT MARKET SIZE, BY MARINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CURING AGENT MARKET SIZE, BY MARINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CURING AGENT MARKET SIZE, BY MARINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CURING AGENT MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CURING AGENT MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CURING AGENT MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CURING AGENT MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CURING AGENT MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CURING AGENT MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CURING AGENT MARKET SIZE, BY SOLID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CURING AGENT MARKET SIZE, BY SOLID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CURING AGENT MARKET SIZE, BY SOLID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CURING AGENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS CURING AGENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL CURING AGENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 174. GCC CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GCC CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 179. GCC CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. GCC CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GCC CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 201. G7 CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. G7 CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. G7 CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 205. G7 CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 206. G7 CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. G7 CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 210. NATO CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. NATO CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. NATO CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 215. NATO CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. NATO CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 218. NATO CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL CURING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES CURING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA CURING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA CURING AGENT MARKET SIZE, BY CURING AGENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA CURING AGENT MARKET SIZE, BY ANHYDRIDE, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA CURING AGENT MARKET SIZE, BY ISOCYANATE, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA CURING AGENT MARKET SIZE, BY PHENOLIC, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA CURING AGENT MARKET SIZE, BY POLYAMINE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA CURING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA CURING AGENT MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA CURING AGENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)